Showing results (821-830 of 1,345) with videos related to
Sort By:
Pageof 135
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 20, 2004
Self-rated health, depression, and one-year health outcomes in older primary care patientsJeffrey M Lyness, Deborah A King, Yeates Conwell, et al.The Journal of Bone and Joint Surgery. American Volume|May 5, 2010
Provider factors associated with intramedullary nail use for intertrochanteric hip fracturesMary L Forte, Beth A Virnig, Lynn E Eberly, et al.The Journal of Bone and Joint Surgery. American Volume|April 3, 2010
Ninety-day mortality after intertrochanteric hip fracture: does provider volume matter?Mary L Forte, Beth A Virnig, Marc F Swiontkowski, et al.Briefings in Bioinformatics|September 30, 2024
HIP: a method for high-dimensional multi-view data integration and prediction accounting for subgroup heterogeneityJessica Butts, Leif Verace, Christine Wendt, et al.Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 11, 2004
Use of a brief Smoking Consequences Questionnaire for Adults (SCQ-A) in African American smokersShawn K Jeffries, Delwyn Catley, Kolawole S Okuyemi, et al.Psychopharmacology|October 31, 2001
Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotineK A Perkins, D Gerlach, M Broge, et al.NPJ Digital Medicine|March 17, 2023
SARAspeech-Feasibility of automated assessment of ataxic speech disturbanceM Grobe-Einsler, J Faber, A Taheri, et al.Communications Biology|January 8, 2026
Scube2 primes Dispatched and ADAM10-mediated Shh release by recruiting HDL acceptors to the plasma membraneJ Puschmann, G Steffes, J Froese, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohortsConnie Marras, Anthony E Lang, Shirley W Eberly, et al.Translational Oncology|November 22, 2021
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancersAnna J Dellomo, Rachel Abbotts, Christian L Eberly, et al.Pageof 135